Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

Many patients with overweight or obesity discontinue GLP-1 receptor agonist therapy within 1 year, with higher discontinuation rates seen for those without type 2 diabetes.

While globally linked to obesity and metabolic disorders, Non-Alcoholic Fatty Liver Disease (NAFLD)'s prevalence in India is ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Consuming high amounts of processed foods, sugar, and unhealthy fats increases the risk of heart disease. Indian diets are ...

Gut health is about how well your body digests food, absorbs nutrients, and maintains a balance of good and bad bacteria.

Western societies are still not near these guidelines, and low fibre consumption remains a major public health issue. Even ...

In honor of American Heart Month, Healio Dermatology interviewed experts and explored the connection between skin disease and heart health.The discovery of this relationship can be traced back to ...

Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

Mental health can impact the heart leading to increased stress hormone secretions thereby causing high BP, irregular ...

The prevention of multiple long term conditions needs to be higher up the healthcare agenda and for this to happen we need to be more precise about what we mean when talking about it. As populations ...

Losing weight isn’t just about feeling better or looking great—it can also have a significant impact on your finances. In ...